Funded Grants

Texas leads the nation in its commitment to the war on cancer. CPRIT has funded 1321 awards for cancer research, product development, and prevention since 2010. The total amount awarded thus far is $2,168,644,161.

Recipients of CPRIT awards include 101 academic institutions, non-profit organizations, and private companies all located in Texas. The research and prevention efforts funded by CPRIT advance the health of Texans, research superiority of the state, life science infrastructure, and the Texas economy. These projects are operating in virtually all regions of the state with Texas-based employees.

Search Instructions

There are four ways to search the grants listed below.

Simple: Enter your search term into the search box above the column you would like to filter. For example, to see grants with a title containing coalition, enter "coalition" into the search box above Title.

Or: To search for grants that contain lung or brain, enter "lung or brain" into the search box above Cancer Type.

And: To search for grants that contain both lung and brain, enter "lung and brain" into the search box above Cancer Type.

Multiple: To search for grants that are part of a coalition that focus on colorectal cancer, enter "coalition" into the search box above Title and "colorectal" into the search box above Cancer Type.

Grant ID Title Program Primary Investigator/ Program Director Institution/ Organization Cancer Type Grant Award Date Contracted Amount
CC121004Biobetter Cancer Monoclonal Antibody ProgramPDEVHoltz, RichardCaliber Biotherapeutics Leukemia, Lymphoma2011/11/02 $12,808,151
CC121020Novel targeted biologics, Engineered Toxin Bodies (ETB), as cancer therapeuticsPDEVKim, JasonMolecular Templates, Inc. Lymphoma2011/11/02 $10,600,000
CP120014Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune StimulantPDEVScott, BrentonPulmotect, Inc. Breast, Leukemia, Lymphoma, Ovary2012/03/29 $7,126,398
CP120017Clinically Actionable Mutation Profiling for Cancer Personalized Medicine using Scalable, Ultra-deep Next Generation SequencingPDEVLatham, GaryAsuragen, Inc. All Sites2012/03/29 $6,837,265
CP120036TexCITE (Texas Cancer ImmunoTherapy Enterprise): Focused development of innovative cell therapies for cancerPDEVSando, GreggCell Medica Lymphoma, Other2012/03/29 $15,571,303
CP120038Formation of The Texas Cancer Therapeutics Process Development LabPDEVFarrell, GerryFujifilm Diosynth Biotechnologies Texas, LLC. All Sites2012/03/29 $7,901,420
CP130013Clinical Development and Commercialization of Oncolytic Adenovirus for Treating Malignant GliomaPDEVTufaro, FrankDNAtrix, Inc. Brain and Other Nervous System2014/02/19 $10,813,623
CP130020Androgen Receptor N-Terminus Blocker Program for Prostate CancerPDEVWood, DavidESSA Pharma Inc. Bone, Other, Prostate2014/02/19 $12,000,000
CP130023Novel Ceramide-modulating Therapeutics for Cancer UsePDEVLove, RichardCerRx, Inc. Lymphoma2014/02/19 $6,000,000
CP130058Developing Two Clinical Proof of Concept Drugs that Inhibit a Novel Cancer Cell TargetPDEVNorthrup, JonathanBeta Cat Pharmaceuticals, LLC Colorectal, Leukemia2014/02/19 $15,908,085
DP140031Pre-IND Development, Phase I Clinical Trials, & Predictive Biomarker Evaluation, for Engineered Human Arginase Targeting the Metabolic Vulnerability of TumorsPDEVWooldridge, JamesAERase, Inc. Bladder, Brain and Other Nervous System, Gallbladder, Head and Neck, Kidney and Renal Pelvis, Leukemia, Liver and Intrahepatic Bile Duct, Lymphoma, Melanoma, Myeloma, Pancreas, Prostate, Sarcoma2014/05/21 $19,806,145
DP140034Preclinical Drug Discovery and Development of Novel, First-In-Class, Small Molecule Compounds That Directly Target Glioblastoma and Other Brain CancersPDEVStein, GregoryCurtana Pharmaceuticals, Inc. Brain and Other Nervous System, Childhood and Adolescent2014/08/20 $7,580,185
DP140067Preclinical and Clinical Development of Synergistic MicroRNA + Targeted Drug CombinationsPDEVO'Neill, VincentMirna Therapeutics, Inc. Gallbladder, Liver and Intrahepatic Bile Duct, Lung and Bronchus2014/05/21 $16,765,076
DP140072OncoNano Medicine: Transforming Cancer Surgery by Tumor IlluminationPDEVSumer, BaranOncoNano Medicine Breast, Head and Neck, Melanoma, Skin2014/08/20 $6,000,000
DP150005Wireless neuromodulation treatment for bladder dysfunction secondary to cancerPDEVKhodaparast, NavidNexeon MedSystems, Inc Cervix Uteri, Prostate2015/05/20 $967,000
DP150021Development of Rhenium Nanoliposomes for Cancer TherapyPDEVBrenner, AndrewNanoTx Therapeutics Brain and Other Nervous System2015/02/18 $2,000,000
DP150029Personalized Cellular Immunotherapy against Novel Cancer TargetsPDEVSteffen, WalterImmatics US Inc. Brain and Other Nervous System, Pancreas2015/02/18 $19,652,175
DP150031A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of CancerPDEVMerchant, FaharMedicenna Therapeutics, Inc. Brain and Other Nervous System2015/02/18 $14,140,090
DP150039Armada Pharmaceuticals Inc. New Company Formation for Development of Anti-Cancer Antibody-Drug Conjugate TherapeuticsPDEVTikhomirov, IliaFormation Biologics Corporation Breast, Head and Neck, Lung and Bronchus, Stomach2015/02/18 $12,750,000
DP150127Engineered AXL Decoy Receptor for Treatment of AML & Solid TumorsPDEVGiaccia, AmatoAravive Biologics, Inc. Leukemia, Ovary, Pancreas2015/11/19 $20,000,000
DP160012Pelican TherapeuticsPDEVHutchins, JeffPelican Therapeutics Bladder, Brain and Other Nervous System, Breast, Colorectal, Corpus and Uterus, NOS, Endocrine, Gallbladder, Head and Neck, Kidney and Renal Pelvis, Leukemia, Liver and Intrahepatic Bile Duct, Lung and Bronchus, Lymphoma, Melanoma, Ovary, Pancreas, Prostate, Sarcoma, Stomach, Thyroid2016/05/18 $15,245,222
DP160014Salarius Pharmaceuticals - Developing epigenetic drugs that treat Rare Pediatric CancersPDEVArthur, DavidSalarius Pharmaceuticals LLC Breast, Leukemia, Prostate, Sarcoma2016/05/18 $18,668,717
DP160057Clinical Evaluation of a Novel T Cell Therapy (BPX-501) for the Treatment of Children and Adults with AMLPDEVWoodard, JosephBellicum Pharmaceuticals, Inc. Leukemia2016/11/16 $16,946,716
DP160071A novel compound targeting CD38 for the treatment of multiple myelomaPDEVKim, JasonMolecular Templates, Inc. Myeloma2016/11/16 $15,200,000*
DP170043Improving the Outcome of Stem Cell Transplants for Cancer Treatment Using Multi-Virus Specific T cellsPDEVLeen, AnnViraCyte LLC Leukemia, Lymphoma2017/08/16 $8,998,067
DP180040Clinical Evaluation of AVID100, a Highly Potent Antibody-Drug Conjugate, Focusing on Cancer Indications With High Unmet Medical NeedPDEVTikhomirov, IliaFormation Biologics Corporation Breast, Head and Neck, Lung and Bronchus2018/08/24 $18,850,000*
DP180042Combination Drug Therapy for Cutaneous T-Cell LymphomaPDEVBarnhart, KerryCerRx, Inc. Lymphoma2018/08/24 $11,783,916*
DP180048Development of KOR-8287 for the Prevention of Chemotherapy-Induced Peripheral Neuropathy and Chemo BrainPDEVHandel, LibbyKorysso Therapeutics, Inc. All Sites2018/08/24 $19,953,624*
R1009Company Recruitment, Relocation and FormationPDEVKutzkey, TimPeloton Therapeutics, Inc. Lung and Bronchus, Multiple Sites2010/06/18 $3,201,002
RP100963Enrichment Filter and Point-of-use Assay Platform for Detection of Circulating Tumor CellsPDEVVykoukal, JodyIngeneron, Inc. Multiple Sites2010/01/20 $198,111
RP101009MRI-Guided Laser Therapy for Targeted Treatment of Localized Prostate CancerPDEVGowda, AshokVisualase, Inc. Prostate2010/01/20 $2,151,776
RP101216Medical Devices for the Treatment of Cancerous Lesions and the Gastrointestinal TractPDEVMcWilliams, DennisApollo Endosurgery Colorectal, Esophagus, Stomach2010/06/18 $5,001,063
RP101219Cancer Treatment Including Drug Discovery/Development and Clinical TrialsPDEVWard, AnaMirna Therapeutics, Inc. Basic Science, Multiple Sites2010/06/18 $10,297,454
RP101287Cancer Biology and Genetics Including Oncogenesis Genomics and ProteomicsPDEVMapes, JamesRules-Based Medicine Multiple Sites2010/06/18 $3,024,432
RP110508Clinical Development of CaspaCIDe, a Cell Therapy Safety SwitchPDEVSlawin, KevinBellicum Pharmaceuticals, Inc. Leukemia, Lymphoma, Myeloma2011/03/24 $5,680,310